Valuation: Femasys Inc.

Market Cap 1.14Cr 1.02Cr 93.77L 85.11L 1.59Cr 108.44Cr 1.62Cr 11Cr 4.46Cr 57Cr 4.27Cr 4.18Cr 179.65Cr P/E 2026 *
-0.52x
P/E 2027 * -0.78x
Enterprise Value 1.14Cr 1.02Cr 93.77L 85.11L 1.59Cr 108.44Cr 1.62Cr 11Cr 4.46Cr 57Cr 4.27Cr 4.18Cr 179.65Cr EV / Sales 2026 *
5.46x
EV / Sales 2027 * 1.27x
Free-Float
96.01%
Yield 2026 *
-
Yield 2027 * -
1 day-3.90%
1 week-17.88%
Current month-37.27%
1 month-43.07%
3 months-53.60%
6 months-81.84%
Current year-88.24%
1 week 1.3
Extreme 1.3
1.59
1 month 1.3
Extreme 1.3
2.24
Current year 1.3
Extreme 1.3
14.51
1 year 1.3
Extreme 1.3
22.2
3 years 1.3
Extreme 1.3
48
5 years 1.3
Extreme 1.3
162
10 years 1.3
Extreme 1.3
275
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2004
Director of Finance/CFO 58 28/02/2022
Chief Operating Officer 52 30/03/2026
Director TitleAgeSince
Chairman 58 01/01/2004
Chairman 74 06/07/2022
Director/Board Member 75 01/08/2005
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Buy

Chief Technology Officer

9,375 0.1166%
07/08/26 Buy

Chief Financial Officer

46,875 0.5832%
07/08/26 Buy

Founder

46,875 0.5832%
Change 5-day change 1-year change 3-year change Capi.($)
-3.90%-17.88%-89.74%-94.11% 1.18Cr
+1.88%+4.04%-17.41%+12.62% 18TCr
+2.55%+4.75%-17.07%+19.03% 12TCr
+2.46%+4.39%+4.16%+39.87% 12TCr
+0.28%+2.53%-43.87%+6.06% 9.1TCr
+1.91%-2.91%-1.52%+76.15% 6.19TCr
-0.32%-0.66%+10.51%+81.65% 5.58TCr
+1.63%+2.06%+7.67%-21.17% 5.32TCr
+2.32%+4.07%-9.20%+47.17% 4.43TCr
+1.94%+5.08%-1.18%-6.94% 3.36TCr
Average +0.70%-0.60%-15.76%+16.03% 7.5TCr
Weighted average by Cap. +1.04%+1.25%-10.85%+26.19%

Financials

2026 *2027 *
Net sales 20.86L 18.64L 17.17L 15.58L 29.16L 20Cr 29.69L 2.05Cr 81.74L 10Cr 78.26L 76.6L 33Cr 89.35L 79.87L 73.56L 66.76L 1.25Cr 85Cr 1.27Cr 8.79Cr 3.5Cr 45Cr 3.35Cr 3.28Cr 140.94Cr
Net income -1.94Cr -1.74Cr -1.6Cr -1.45Cr -2.72Cr -184.94Cr -2.77Cr -19Cr -7.61Cr -97Cr -7.29Cr -7.13Cr -306.37Cr -2.29Cr -2.04Cr -1.88Cr -1.71Cr -3.2Cr -217.71Cr -3.26Cr -22Cr -8.96Cr -114.09Cr -8.58Cr -8.4Cr -360.67Cr
Net Debt - -
Projected Income Statement - Annual - Femasys Inc.
Logo Femasys Inc.
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Employees
53
Date Price Change Volume
29/26/29 $1.360 -3.55% 1,10,303
28/26/28 $1.410 +2.92% 63,433
27/26/27 $1.370 -2.84% 2,28,771
26/26/26 $1.410 -6.00% 1,10,574
23/26/23 $1.500 -3.85% 1,26,304
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Femasys Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.360USD
Average target price
14.33USD
Spread / Average Target
+953.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Femasys Inc.
  1. Stock Market
  2. Stocks
  3. FEMY Stock